Literature DB >> 11160223

Differential transcriptional regulation of individual TCR V beta segments before gene rearrangement.

F Chen1, L Rowen, L Hood, E V Rothenberg.   

Abstract

The promoter sequences of individual murine TCR Vbeta segments are dissimilar, but any functional differences between them are masked after productive gene rearrangement by the dominance of the TCRbeta 3' enhancer. However, thymocytes of recombination-activating gene-2 (Rag2)-deficient mice allow the transcriptional activity of Vbeta promoters to be studied before rearrangement. Here we report that many Vbeta segments are detectably transcribed in Rag2(-/-) thymocytes and that there are significant differences in expression among different Vbeta segments. Primer extension and characterization of cDNA clones from SCID thymocytes suggest that these germline Vbeta transcripts generally use the same start sites as those previously determined in mature T cells. The strength of expression before rearrangement does not correlate with proximity to the known enhancer, because members of the most distal Vbeta cluster (Vbeta2.1, Vbeta1.1, Vbeta4.1) are relatively strongly expressed and more proximal Vbeta segments (Vbeta14.1, Vbeta3.1, Vbeta7.1, Vbeta6.1) are only weakly expressed. Different Vbeta segments also show different developmental programs of activation in different thymocyte subsets, with the Vbeta5.1(L)-8.2(V) spliced transcript expressed earliest as well as most strongly overall. Comparison with Rag(+) MHC class I(-/-) and class II(-/-) thymocytes confirms that many of these expression differences are leveled by rearrangement and/or by beta selection, before MHC-dependent selection. However, the expression pattern of Vbeta2.1 is highly distinctive and includes cell types apparently outside the T lineage, suggesting potential acquisition of specialized roles.

Entities:  

Mesh:

Year:  2001        PMID: 11160223     DOI: 10.4049/jimmunol.166.3.1771

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Determinants of public T cell responses.

Authors:  Hanjie Li; Congting Ye; Guoli Ji; Jiahuai Han
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

2.  Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 3.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

Review 4.  Launching the T-cell-lineage developmental programme.

Authors:  Ellen V Rothenberg; Jonathan E Moore; Mary A Yui
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

5.  Germline transcription from T-cell receptor Vbeta gene is uncoupled from allelic exclusion.

Authors:  Jingquan Jia; Motonari Kondo; Yuan Zhuang
Journal:  EMBO J       Date:  2007-04-05       Impact factor: 11.598

6.  Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.

Authors:  Julie E Horowitz; Craig H Bassing
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

7.  HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.

Authors:  Umesh S Deshmukh; Davis L Sim; Chao Dai; Carol J Kannapell; Felicia Gaskin; Govindarajan Rajagopalan; Chella S David; Shu Man Fu
Journal:  J Autoimmun       Date:  2011-08-24       Impact factor: 7.094

8.  E proteins are required to activate germline transcription of the TCR Vbeta8.2 gene.

Authors:  Jingquan Jia; Meifang Dai; Yuan Zhuang
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

9.  T lymphoid differentiation in human bone marrow.

Authors:  Florian Klein; Niklas Feldhahn; Sanggyu Lee; Hui Wang; Fiammetta Ciuffi; Mirko von Elstermann; María L Toribio; Heinrich Sauer; Maria Wartenberg; Varun Singh Barath; Martin Krönke; Peter Wernet; Janet D Rowley; Markus Müschen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

10.  CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors.

Authors:  Angela M Tatum; Lawrence M Mylin; Susan J Bender; Matthew A Fischer; Beth A Vigliotti; M Judith Tevethia; Satvir S Tevethia; Todd D Schell
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.